Back to
Belvedere Trading LLC
TNGX
3 quarters
Position history for
Belvedere Trading LLC's holdings in Tango Therapeutics, Inc.
No. Belvedere Trading exited its TNGX (Tango Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 10,845 shares worth $91,098. Belvedere Trading first reported TNGX in Q2 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$57,503
Total Shares Change
-11,231
Quarter-by-Quarter History